Hifas da Terra (HdT) makes a significant contribution to research into natural products for human health with a new clinical trial on breast cancer, which is the last phase of the Microimmunomama project, led by HdT since 2019. This collaborative project, in partnership with IIS Galicia Sur (IISGS) and the technological centre Leitat, consists of studying the benefits for breast cancer patients of newly developed medicinal mushroom based nutritional supplements capable of modulating the immune response and the intestinal microbiota.
Hifas da Terra (HdT) and Cuevas y Cía announced the results of the trial carried out at the Foltra Health Centre (Foltra Foundation), which shows that the daily intake of a new functional food has a significant impact on critical aspects of neurological health such as memory and attention, and may also be useful in cognitive impairment associated with conditions such as Alzheimer’s disease.
The overall objective of the R&D&I project ‘NutriGen 4.0’ is to design a biotechnological process, which can monitor, simulate and predict outcomes so nutraceuticals can be created by means of advanced calculation and modelling tools.
There are multiple situations that compromise your immunity and the state of your gut microbiota is one of the most important. Find out why you should take care of the microorganisms that inhabit your digestive tract and what foods and nutrients help you to do this.
Hifas da Terra’s released the preliminary results of the trial of mycotherapeutic supplements in nursing home residents diagnosed with COVID-19, which demonstrated that supplementation with immunomodulatory nutraceuticals can significantly improve the situation of those most vulnerable to the pandemic by reducing both mortality and complications associated with infection by SARS-COV-2.